Early research (Phase 1)UnknownNCT05007418
What this trial is testing
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma
Who this might be right for
Multiple Myeloma
Sorrento Therapeutics, Inc. 54